FDA approves Spravato, first monotherapy nasal spray to treat depression
The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.
Hosted on MSN17m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
Managed Healthcare Executive5h
FDA Approves Spravato Nasal Spray as a Standalone Treatment for Major Depressive Disorder
One-third of folks with major depressive disorder experience treatment-resistant depression (TRD), a condition that makes it ...
KALW6h
FDA allows standalone use of nasal spray antidepressant Spravato (esketamine)
The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...
btimesonline15h
FDA Approves Johnson & Johnson's Spravato as Standalone Treatment for Depression
The Food and Drug Administration has approved Johnson & Johnson's nasal spray Spravato (esketamine) as a standalone treatment ...
STAT9d
Pharmalittle: We’re reading about J&J and GSK deals, a departing FDA official, and more
The move by J&J, which also sells Spravato for treatment-resistant depression, reflects how the pharmaceutical industry has come back to neuropsychiatric drug development after largely leaving the ...
KXAN7d
Innovative, Life Changing TMS Therapy for Depression at New Directions Mental Health
NeuroStar TMS is FDA-cleared for the treatment of Major Depressive ... medication management, Spravato treatment, and psychological testing and evaluation, visit https://newdirectionspgh.com ...
Psychology Today4d
Psychiatrists in Mercer County, NJ
View cities in Mercer County Female Male ...
Yahoo Finance23d
Relief Mental Health Honored with BEST of 2024 Award in Red Bank, NJ
SPRAVATO® (Esketamine): SPRAVATO® is an innovative treatment for treatment-resistant depression or depression with suicidal thoughts or actions. Administered under medical supervision, this ...
Psychology Today29d
Tri America TMSKeta
Ketamine and its analogues like Spravato (FDA approved in 2019) are also being used for treatment-resistant depression and/or suicidality. Spravato is a nasal spray that is delivered in a our ...